Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Center, Prospective Study of Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B Cirrhosis

NCT05106972 is registered in ClinicalTrials.gov with Asia Stem Cell Regenerative Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT05106972
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05106972 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Center, Prospective Study of Umbilical Cord Mesenchymal Stem Cell Transplantation for Decompensated Hepatitis B Cirrhosis
Lead sponsor
Asia Stem Cell Regenerative Pharmaceutical Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
December 1, 2021
Completion date
December 31, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cirrhosis